Overview of modulator therapies that target dysbiotic conditions and their current relevance. NAFLD, nonalcoholic fatty liver disease; CDI, Clostridium difficile infection; IBD, inflammatory bowel disease; IBS, irritable bowel syndrome; UC, ulcerative colitis; CD, Crohn's disease; FMT, fecal microbiota transplant.